At a glance
- Originator Vertex Pharmaceuticals
- Class Antivirals
- Mechanism of Action Hepatitis C virus NS3 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 13 Dec 2002 Discontinued - Preclinical for Hepatitis C in USA (unspecified route)
- 16 Aug 1999 New profile
- 16 Aug 1999 Preclinical development for Hepatitis C in USA (Unknown route)